Effects of Paclitaxel on Intimal Hyperplasia

Completed · Not applicable

Conditions studied: Peripheral Vascular Disease

In brief

This is a single, one time, limited dose infusion of Paclitaxel, that will potentially prevent recurrent stenosis secondary to intimal hyperplasia when compared to the control group at 10 months.

Key facts

Study ID

NCT01454778

Run by

Patrick Kelly

People needed

50

Starts

2011-04-01

Expected to finish

2015-04-01

Last updated by the study team

2016-05-24

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• ability to provide informed consent
• age 18-90 years old
• Rutherford 1-6
• occlusion or stenosis in the infrainguinal vessels

You may not qualify if…

• inability to pass the guide wire across the lesion
• pregnant or lactating women
• specific limb has not been previously treated with endovascular intervention

Where it is running

• Sanford Vascular Associates — Sioux Falls, South Dakota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.